Atypical Pneumonia

计划入组 45 人 · 首次发布于 2024 年 12 月 10 日

Clinical Registry of Patients Under Treatment With Atypical Antipsychotics

计划入组 665 人 · 首次发布于 2015 年 4 月 7 日

Berberine Effects on Clinical Symptoms and Metabolic Disturbance in Patients With Schizophrenia

计划入组 65 人 · 首次发布于 2018 年 6 月 7 日

atypical antipsychotics (Lilly)

B7-H3(Radiopharm Ventures)

histone acetyltransferase activators (Columbia University/Columbia Technology Ventures)

AMARA VENTURES

India

Stoh Ventures, Inc.

United States

Endo Ventures Limited

United States

Parallel Bio Raises $21 Million Series A to Revolutionize Drug Discovery with Human Organoid Platform

FDA Approves Cobenfy, a Novel Muscarinic Receptor-Targeting Drug for Schizophrenia

Shennon Biotechnologies Raises $12M, Names Cyril Konto CEO and Unveils Three T-Cell Engager Programs